Published in Psychopharmacology (Berl) on February 05, 2005
Central cholinergic involvement in sequential behavior: impairments of performance by atropine in a serial multiple choice task for rats. Neurobiol Learn Mem (2013) 0.82
Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine. Psychopharmacology (Berl) (2010) 0.75
Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull (1993) 6.87
Time, rate, and conditioning. Psychol Rev (2000) 6.04
Scalar timing in memory. Ann N Y Acad Sci (1984) 5.86
International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev (1998) 5.34
Probability of shock in the presence and absence of CS in fear conditioning. J Comp Physiol Psychol (1968) 4.38
Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev (1992) 4.06
Central cholinergic systems and cognition. Annu Rev Psychol (1997) 3.80
Neural substrates of eyeblink conditioning: acquisition and retention. Learn Mem (2003) 3.50
Neuropharmacology of timing and time perception. Brain Res Cogn Brain Res (1996) 2.89
Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem (2003) 1.63
Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect. Psychopharmacology (Berl) (2005) 1.43
Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis. Neuropsychopharmacology (1999) 1.37
Cholinergic modulation of the content of temporal memory. Behav Neurosci (1987) 1.09
Scopolamine selectively disrupts the acquisition of contextual fear conditioning in rats. Neurobiol Learn Mem (1995) 1.08
The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: comparing pavlovian fear conditioning and inhibitory avoidance. Learn Mem (2004) 1.08
The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons. J Neurosci (2000) 1.06
Effect of signaling intertrial unconditioned stimuli in autoshaping. J Exp Psychol Anim Behav Process (1983) 1.05
Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning. Neurobiol Learn Mem (1996) 1.02
Context-specific conditioning in the conditioned-emotional-response procedure. J Exp Psychol Anim Behav Process (1990) 0.96
Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioning. Neurobiol Learn Mem (1995) 0.92
The comparator hypothesis of conditioned response generation: manifest conditioned excitation and inhibition as a function of relative excitatory strengths of CS and conditioning context at the time of testing. J Exp Psychol Anim Behav Process (1987) 0.91
A computational model of cholinergic disruption of septohippocampal activity in classical eyeblink conditioning. Neurobiol Learn Mem (1996) 0.88
Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice. Psychopharmacology (Berl) (2001) 0.88
The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology (Berl) (2000) 0.87
Modulation of cholinergic transmission enhances excitability of hippocampal pyramidal neurons and ameliorates learning impairments in aging animals. Neurobiol Learn Mem (2003) 0.86
Context-dependent information processing in patients with schizophrenia. Schizophr Res (2000) 0.85
Galantamine facilitates acquisition of a trace-conditioned eyeblink response in healthy, young rabbits. Learn Mem (2004) 0.84
Cholinergic facilitation of trace eyeblink conditioning in aging rabbits. Life Sci (1999) 0.83
Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer's disease. Behav Brain Res (2000) 0.82
A change of context can enhance performance of an aversive but not of an appetitive conditioned response. Q J Exp Psychol B (1990) 0.81
The effects of AMPA-induced lesions of the septo-hippocampal cholinergic projection on aversive conditioning to explicit and contextual cues and spatial learning in the water maze. Eur J Neurosci (1995) 0.78
Enhancement of passive avoidance learning through small doses of intra-amygdaloid physostigmine in the young rat. Its relation to the development of acetylcholinesterase. Dev Psychobiol (1988) 0.78
Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamine. Behav Neurosci (1993) 0.75
Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect. Psychopharmacology (Berl) (2005) 1.43
Propofol anesthesia significantly alters plasma blood levels of melatonin in rats. Anesthesiology (2010) 1.42
Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology (2002) 1.09
In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg (2002) 1.06
Involvement of the basal cholinergic forebrain in the mediation of general (propofol) anesthesia. Anesthesiology (2008) 0.87
Effect of a nonsedative dose of propofol on memory for aversively loaded information in rats. Anesthesiology (2002) 0.84
Reciprocal relationships between general (Propofol) anesthesia and circadian time in rats. Neuropsychopharmacology (2006) 0.83
Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia. Neurosci Biobehav Rev (2002) 0.83
The anesthetics propofol and ketamine inhibit cocaine-induced egr-1 gene expression in rat forebrain. Eur J Pharmacol (2002) 0.82
General anesthetics effects on circadian temporal structure: an update. Chronobiol Int (2008) 0.82
Texture analysis of brain MRI evidences the amygdala activation by nociceptive stimuli under deep anesthesia in the propofol-formalin rat model. Magn Reson Imaging (2006) 0.80
Circadian disruption of body core temperature and rest-activity rhythms after general (propofol) anesthesia in rats. Anesthesiology (2009) 0.79
Delayed aversive effects of high-dose fentanyl. Prevention by a polyamine-deficient diet. Behav Brain Res (2008) 0.77
Disruption of the circadian system by environmental factors: Effects of hypoxia, magnetic fields and general anesthetics agents. Adv Drug Deliv Rev (2010) 0.76
Labor pain, analgesia, and chronobiology: what factor matters? Anesth Analg (2010) 0.75
Plasma corticosterone in rats is specifically increased at recovery from propofol anesthesia without concomitant rise of plasma ACTH. Chronobiol Int (2009) 0.75
Fos immunolabelling evidence for brain regions involved in the Pavlovian degraded contingency effect and in its disruption by atropine. Neuropharmacology (2006) 0.75
Prefrontal cortex and reversion of atropine-induced disruption of the degraded contingency effect by antipsychotic agents and N-desmethylclozapine in rats. Int J Neuropsychopharmacol (2009) 0.75